Business
MedX Holdings, Inc. (OTC: MEDH) Announces Record Q1 2025 Revenue and Strategic Advances Across Cannabis, Retail Tech, and Franchise Growth
MedX Holdings, Inc. (OTC: MEDH) Announces Record Q1 2025 Revenue and Strategic Advances Across Cannabis, Retail Tech, and Franchise Growth.
About this update from Medx Holdings, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n MedX Holdings, Inc. (OTC: MEDH) Announces Record Q1 2025 Revenue and Strategic Advances Across Cannabis, Retail Tech, and Franchise Growth\r\n \r\n \r\n\r\n\r\nMedX Holdings, Inc. (OTC: MEDH) Announces Record Q1 2025 Revenue and Strategic Advances Across Cannabis, Retail Tech, and Franchise Growth\r\n\r\n\r\n\r\n\r\n\r\nAustin, Texas, May 20, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) Reports Record Q1 2025 Revenue and Announces Strategic Milestones in Retail Technology, AI, and Cannabis Expansion Austin, TX – May 20, 2025 – MedX Holdings, Inc. (OTC: MEDH), the parent company of Lazydaze + Coffeeshop and Dazed Inc., announced its unaudited financial results for the first quarter of 2025 along with key strategic developments that continue to position the company as a leader in cannabis retail, technology, and lifestyle franchise operations. For the quarter ended March 31, 2025, MedX Holdings delivered its strongest financial performance to date, driven by accelerating revenue growth, solid gross margins, and improved operational efficiency. Revenue more than tripled year-over-year, fueled by expanded retail activity, strategic acquisitions, and increased consumer demand across the Lazydaze franchise network. The company maintained a healthy gross margin profile, improved cost control and strong unit economics. Net income surged to a new high, reflecting a significant turnaround in bottom-line profitability. MedX also reinforced its balance sheet strength, increasing total stockholders’ equity while successfully reducing liabilities—a clear signal of momentum and prudent capital management heading into the next phase of expansion. MedX is currently raising $10 million through a convertible note offering to support its next phase of growth. Executives are actively engaging with investors and financials groups , and aniticiapates clsoing the round by end of Q2. The proceeds will be used to complete a full audit, fund capital expenditures, purchase pre-roll manufacturing equipment, and secure flagship retail properties in key markets. The company also announced the launch of an AI-driven commerce initiative, which includes the development of mobile vending machines powered by proprietary artificial intelligence technology and the rollout of AI Budtende...